
Jammu CSIR lab finds cannabis plant compound has antibiotic effects | Explained Premium
The Hindu
Semisynthetic phytocannabinoid compounds possesses unexplored hitherto antibiotic properties that could help combat antibiotic resistance in India, according to the findings of a new study published by scientists at the CSIR-Indian Institute of Integrative Medicine in Jammu.
Cannabis has the potential to make a dent in India’s fight against the escalating threat of antibiotic resistance.
Scientists at CSIR-Indian Institute of Integrative Medicine (IIIM), Jammu, have found that phytocannabinoids, a class of compounds found in the cannabis plant, possess some hitherto unexplored antibiotic properties.
Antimicrobial resistance (AMR) is a major health concern worldwide. It refers to when bacteria, viruses, fungi, and parasites no longer respond to medicines used to treat them.
According to Sanghapal D. Sawant, a senior principal scientist at the CSIR-National Chemical Laboratory (NCL), Pune, bacteria have developed certain sophisticated ‘shields’ over many decades to resist the effects of antibiotic medications.
These include the formation of biofilms – thin sheets of bacterial colonies that are more resistant to antibiotics than when separated – and cellular mechanisms called efflux pumps that flush drugs out from cells.
The resulting AMR increases the risk of disease spread, severe illness, and death.
According to one estimate, India reported 2.97 lakh deaths in 2019 that could be attributed to AMR and 10.42 lakh others that could be associated with AMR.

Climate scientists and advocates long held an optimistic belief that once impacts became undeniable, people and governments would act. This overestimated our collective response capacity while underestimating our psychological tendency to normalise, says Rachit Dubey, assistant professor at the department of communication, University of California.






